Developing a model to evaluate strategies for controlling influenza outbreaks
RFA-IP-22-004, Modeling toolkit to evaluate multifaceted control strategies for seasonal and pandemic influenza
This study is working on a new way to understand how the flu spreads in the U.S. so that we can find better ways to protect everyone, especially during flu season and pandemics, and the results could help improve health strategies for people like you.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10907392 on NIH RePORTER |
What this research studies
This research focuses on creating a detailed model to understand how seasonal and pandemic influenza spreads across the United States. By collaborating with the CDC, the team aims to enhance the accuracy and transparency of the model, which will assess various intervention strategies such as vaccines, antivirals, and social distancing. The model will consider factors like age, risk groups, and local conditions to evaluate the effectiveness of different control measures. Patients may benefit from improved public health policies and interventions based on the findings of this research.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals at higher risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or who have already been vaccinated may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective strategies for preventing and controlling influenza outbreaks, ultimately saving lives.
How similar studies have performed: Previous research has shown success in using modeling approaches to evaluate public health interventions for infectious diseases, indicating that this methodology is both tested and promising.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Meyers, Lauren Ancel — University of Texas at Austin
- Study coordinator: Meyers, Lauren Ancel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.